清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

内科学 cGMP特异性磷酸二酯酶5型
作者
Irwin Goldstein,Tom F. Lue,Harin Padma-Nathan,Raymond C. Rosen,William D. Steers,Pierre A. Wicker
出处
期刊:The New England Journal of Medicine [New England Journal of Medicine]
卷期号:338 (20): 1397-1404 被引量:1821
标识
DOI:10.1056/nejm199805143382001
摘要

BACKGROUND Sildenafil is a potent inhibitor of cyclic guanosine monophosphate hydrolysis [corrected] in the corpus cavernosum and therefore increases the penile response to sexual stimulation. We evaluated the efficacy and safety of sildenafil, administered as needed in two sequential double-blind studies of men with erectile dysfunction of organic, psychogenic, and mixed causes. METHODS In a 24-week dose-response study, 532 men were treated with oral sildenafil (25, 50, or 100 mg) or placebo. In a 12-week, flexible dose-escalation study, 329 different men were treated with sildenafil or placebo, with dose escalation to 100 mg based on efficacy and tolerance. After this dose-escalation study, 225 of the 329 men entered a 32-week, open-label extension study. We assessed efficacy according to the International Index of Erectile Function, a patient log, and a global-efficacy question. RESULTS In the dose-response study, increasing doses of sildenafil were associated with improved erectile function (P values for increases in scores for questions about achieving and maintaining erections were <0.001). For the men receiving 100 mg of sildenafil, the mean score for the question about achieving erections was 100 percent higher after treatment than at base line (4.0 vs. 2.0 of a possible score of 5). In the last four weeks of treatment in the dose-escalation study, 69 percent of all attempts at sexual intercourse were successful for the men receiving sildenafil, as compared with 22 percent for those receiving placebo (P<0.001). The mean numbers of successful attempts per month were 5.9 for the men receiving sildenafil and 1.5 for those receiving placebo (P<0.001). Headache, flushing, and dyspepsia were the most common adverse effects in the dose-escalation study, occurring in 6 percent to 18 percent of the men. Ninety-two percent of the men completed the 32-week extension study. CONCLUSIONS Oral sildenafil is an effective, well-tolerated treatment for men with erectile dysfunction.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
无悔完成签到 ,获得积分10
5秒前
7秒前
科研通AI6应助科研小菜鸟采纳,获得10
10秒前
NexusExplorer应助科研通管家采纳,获得10
25秒前
ceeray23应助科研通管家采纳,获得10
25秒前
25秒前
1分钟前
ceeray23发布了新的文献求助20
1分钟前
JESI完成签到,获得积分10
1分钟前
sube完成签到 ,获得积分10
1分钟前
jesi完成签到,获得积分10
1分钟前
赵芳完成签到,获得积分10
1分钟前
Cassie关注了科研通微信公众号
1分钟前
vbnn完成签到 ,获得积分10
2分钟前
2分钟前
缓慢雨南发布了新的文献求助10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
Lucas应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
ceeray23应助科研通管家采纳,获得10
2分钟前
2分钟前
kgf完成签到 ,获得积分20
2分钟前
曹国庆完成签到 ,获得积分10
2分钟前
orixero应助ceeray23采纳,获得20
2分钟前
斯文败类应助ceeray23采纳,获得20
2分钟前
3分钟前
3分钟前
袁青寒发布了新的文献求助10
3分钟前
科研通AI2S应助ceeray23采纳,获得20
3分钟前
热带蚂蚁完成签到 ,获得积分10
3分钟前
云锋完成签到,获得积分10
3分钟前
Cassie完成签到,获得积分10
3分钟前
3分钟前
ceeray23发布了新的文献求助20
3分钟前
jsinm-thyroid完成签到 ,获得积分10
4分钟前
qinghe完成签到 ,获得积分10
4分钟前
铁瓜李完成签到 ,获得积分10
4分钟前
领导范儿应助科研通管家采纳,获得10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5599887
求助须知:如何正确求助?哪些是违规求助? 4685645
关于积分的说明 14838712
捐赠科研通 4672874
什么是DOI,文献DOI怎么找? 2538369
邀请新用户注册赠送积分活动 1505574
关于科研通互助平台的介绍 1470965